个性化文献订阅>期刊> Blood
 

Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study

  作者 Kanda, J; Saji, H; Fukuda, T; Kobayashi, T; Miyamura, K; Eto, T; Kurokawa, M; Kanamori, H; Mori, T; Hidaka, M; Iwato, K; Yoshida, T; Sakamaki, H; Tanaka, J; Kawa, K; Morishima, Y; Suzuki, R; Atsuta, Y; Kanda, Y  
  选自 期刊  Blood;  卷期  2012年119-10;  页码  2409-2416  
  关联知识点  
 

[摘要]To clarify which is preferable, a related donor with an HLA-1 Ag mismatch at the HLA-A, HLA-B, or HLA-DR loci in the graft-versus-host (GVH) direction (RD/1AG-MM-GVH) or an HLA 8/8-allele (HLA-A, HLA-B, HLA-C, and HLA-DRB1)-matched unrelated donor (8/8-MUD), we evaluated 779 patients with acute leukemia, chronic myelogenous leukemia, or myelodysplastic syndrome who received a T cell-replete graft from an RD/1AG-MM-GVH or 8/8-MUD. The use of an RD/1AG-MM-GVH donor was significantly associated with a higher overall mortality rate than the use of an 8/8-MUD in a multivariate analysis (hazard ratio, 1.49; P<.001), and this impact was statistically significant only in patients with standard-risk diseases (P=.001). Among patients with standard-risk diseases who received transplantation from an RD/1AG-MM-GVH donor, the presence of an HLA-B Ag mismatch was significantly associated with a lower overall survival rate than an HLA-DR Ag mismatch because of an increased risk of treatment-related mortality. The HLA-C Ag mismatch or multiple allelic mismatches were frequently observed in the HLA-B Ag-mismatched group, and were possibly associated with the poor outcome. In conclusion, an 8/8-MUD should be prioritized over an RD/1AG-MM-GVH donor during donor selection. In particular, an HLA-B Ag mismatch in the GVH direction has an adverse effect on overall survival and treatment-related mortality in patients with standard-risk diseases. (Blood. 2012;119(10):2409-2416)

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内